FindTrial
Sign In

Gabapentin as adjuvant to analgesics in pre-emptive analgesia

ASSESSING THE EFFICACY OF GABAPENTIN AS ADJUVANT TO ANALGESICS IN PRE-EMPTIVE ANALGESIA IN MANDIBULAR THIRD MOLAR SURGERIES-A COMPARITIVE CLINICAL STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043330
Enrollment
18
Registered
2022-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K011- Impacted teeth

Interventions

Intervention1: Cap. GABAPENTIN 300 mg Tab. ETORICOXIB 120 mg : Cap. GABAPENTIN 300 mg & Tab. ETORICOXIB 120 mg 2 hours prior to surgical extraction of mandibular third molars intra orally Control Int

Sponsors

B Sujan Sekhar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Physical status classification system-American Society of Anaesthesiology Class1&2 in age group 20-45 years 2.Subjects must be willing and able to comply with the protocol requirements. 3.subjects must be able to understand the Informed consent and must be able to sign a written Informed consent form prior to the initiation of any study procedure

Exclusion criteria

Exclusion criteria: 1.Hypersensitivity to gabapentinoids 2.History of chronic opioid or gabapentin usage

Design outcomes

Primary

MeasureTime frame
gabapentin makes positive effect on achieving effective analgesia post operativelyTimepoint: gabapentin makes positive effect on achieving effective analgesia at 3,6,12,24 and 72 hrs post operatively—

Secondary

MeasureTime frame
pre medicated with gabapentin is not equal to placebo groupTimepoint: intra operative and post operative—

Countries

India

Contacts

Public ContactDrBSujan Sekhar

Sibar Institute of Dental Sciences

sujansekhar07@gmail.com8790077335

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026